http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1980571-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d8fc19800f5d2a18cc8cc5b03d6d92 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2007-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_704b2327d087368a4ee6bd5ba4d4ecd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e81ddcc323a1967d6271cdf23fdcfa8e |
| publicationDate | 2008-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1980571-A1 |
| titleOfInvention | Anti-tumor drug, medicament, composition, and use thereof |
| abstract | The present invention relates to an active polypeptide comprising the amino acid sequence of SEQ ID NO:3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO:3, or fragments thereof having at least 21 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of said fragments, provided that said polypeptide is not SEQ ID NO:2. |
| priorityDate | 2007-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 291.